Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Nathan

Showing results (1-10 of 297) with videos related to

Pageof 30
Sort By:
Chest|June 8, 2020
POINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? YesSteven D Nathan
Chest|June 8, 2020
Rebuttal From Dr NathanSteven D Nathan
The Lancet. Respiratory Medicine|April 7, 2016
Antacid therapy and idiopathic pulmonary fibrosis: cause for heartburn?Steven D Nathan
Clinics in Chest Medicine|March 21, 2006
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approachSteven D Nathan
The European Respiratory Journal|August 2, 2014
Hypersensitivity pneumonitis and pulmonary hypertension: how the breeze affects the squeezeSteven D Nathan
Chest|March 15, 2005
Lung transplantation: disease-specific considerations for referralSteven D Nathan
The American Journal of Managed Care|October 6, 2017
Evaluating new treatment optionsSteven D Nathan
American Journal of Respiratory and Critical Care Medicine|May 9, 2023
Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung DiseaseSteven D Nathan
American Journal of Respiratory and Critical Care Medicine|August 20, 2019
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. Echoes of the Past, Lessons for the FutureSteven D Nathan
Thorax|June 1, 2025
Early phase clinical trials in pulmonary hypertension: how small is big enough?Steven D Nathan
Pageof 30

Showing results (1-10 of 297) with videos related to

Sort By:
Pageof 30
Chest|June 8, 2020
POINT: Should Every Patient With Idiopathic Pulmonary Fibrosis Be Referred for Transplant Evaluation? YesSteven D Nathan
Chest|June 8, 2020
Rebuttal From Dr NathanSteven D Nathan
The Lancet. Respiratory Medicine|April 7, 2016
Antacid therapy and idiopathic pulmonary fibrosis: cause for heartburn?Steven D Nathan
Clinics in Chest Medicine|March 21, 2006
Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approachSteven D Nathan
The European Respiratory Journal|August 2, 2014
Hypersensitivity pneumonitis and pulmonary hypertension: how the breeze affects the squeezeSteven D Nathan
Chest|March 15, 2005
Lung transplantation: disease-specific considerations for referralSteven D Nathan
The American Journal of Managed Care|October 6, 2017
Evaluating new treatment optionsSteven D Nathan
American Journal of Respiratory and Critical Care Medicine|May 9, 2023
Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung DiseaseSteven D Nathan
American Journal of Respiratory and Critical Care Medicine|August 20, 2019
Nintedanib and Sildenafil in Patients with Idiopathic Pulmonary Fibrosis. Echoes of the Past, Lessons for the FutureSteven D Nathan
Thorax|June 1, 2025
Early phase clinical trials in pulmonary hypertension: how small is big enough?Steven D Nathan
Pageof 30